Irisin mitigates osteoporotic-associated bone loss and gut dysbiosis in ovariectomized mice by modulating microbiota, metabolites, and intestinal barrier integrity
Abstract Background Osteoporotic bone defects significantly affect patient health and quality of life. The gut-bone axis plays a crucial role in osteoporosis, and disruptions in gut microbiota are linked to systemic inflammation and compromised bone metabolism. Irisin, a myokine, has shown potential...
Saved in:
| Main Authors: | Yiran Wang, Huimin Deng, Zhihui Zhang, Hongbo Wu, Xiaofeng Wang, Zhiwen Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Musculoskeletal Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12891-025-08622-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Irisin reshapes bone metabolic homeostasis to delay age-related osteoporosis by regulating the multipotent differentiation of BMSCs via Wnt pathway
by: Shangman Xing, et al.
Published: (2025-01-01) -
Irisin and neuroinflammation: Challenges and opportunities
by: Erika Yolanda Hernández Sandoval, et al.
Published: (2024-12-01) -
Irisin Attenuates Neuroinflammation Targeting the NLRP3 Inflammasome
by: Francesca Martina Filannino, et al.
Published: (2024-11-01) -
Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway
by: Jie Mao, et al.
Published: (2024-12-01) -
Correlation of irisin with lipid profile in type 2 diabetes mellitus
by: Wahengbam Diana Devi, et al.
Published: (2025-02-01)